Rimonabant brand name availability
NEW YORK - An HSBC analyst upgraded Sanofi-Aventis SA Wednesday,Rimonabant brand citing the French drug maker's full pipeline and shrugging off its failure to receive U.S. approval for the weight-loss drug Acomplia.In late June, Sanofi-Aventis (nyse: SNY - news - people ) withdrew its application to gain U.S. approval for ...